These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 6178608)

  • 1. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL; Boon T
    Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response.
    Maryanski JL; Van Snick J; Cerottini JC; Boon T
    Eur J Immunol; 1982 May; 12(5):401-6. PubMed ID: 6178607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. V. H-2 associativity of variant-specific antigens.
    Van Snick J; Maryanski J; Van Pel A; Parmiani G; Boon T
    Eur J Immunol; 1982 Nov; 12(11):905-8. PubMed ID: 6818041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour cell variants with increased immunogenicity obtained by mutagen treatment.
    Boon T; Maryanski J
    Cancer Surv; 1985; 4(1):135-48. PubMed ID: 3879855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants.
    Maryanski JL; Marchand M; Uyttenhove C; Boon T
    Int J Cancer; 1983 Jan; 31(1):119-23. PubMed ID: 6187698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hapten-specific cytotoxic T cell clones undergo somatic variation of their antigen recognition specificity.
    Weltzien HU; Kempkes B; Jankovic DL; Eichmann K
    Eur J Immunol; 1986 Jun; 16(6):631-9. PubMed ID: 2424767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
    Jones B; Tite JP; Janeway CA
    J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation of specificity in cytolytic T lymphocyte clones: two broad specificity, H-2-independent recognition systems, one natural killer-like, develop during culture, in addition to the clonally distributed antigen-specific receptor.
    Wilson A; Shortman K
    Eur J Immunol; 1985 Sep; 15(9):899-905. PubMed ID: 2412835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells.
    Maryanski JL; Accolla RS; Jordan B
    J Immunol; 1986 Jun; 136(12):4340-7. PubMed ID: 3086429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VII. Dominant expression of variant antigens in somatic cell hybrids.
    Maryanski JL; Szpirer J; Szpirer C; Boon T
    Somatic Cell Genet; 1983 May; 9(3):345-57. PubMed ID: 6407125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815.
    Brichard VG; Warnier G; Van Pel A; Morlighem G; Lucas S; Boon T
    Eur J Immunol; 1995 Mar; 25(3):664-71. PubMed ID: 7705394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
    Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
    J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression.
    Uyttenhove C; Maryanski J; Boon T
    J Exp Med; 1983 Mar; 157(3):1040-52. PubMed ID: 6187879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones.
    Tanaka Y; Tevethia SS
    J Immunol; 1988 Jun; 140(12):4348-54. PubMed ID: 2453578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele.
    Szikora JP; Van Pel A; Brichard V; André M; Van Baren N; Henry P; De Plaen E; Boon T
    EMBO J; 1990 Apr; 9(4):1041-50. PubMed ID: 2108859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of specificity in cytolytic T lymphocyte clones. The separate YAC-1-type (NK-like) and P815-type broad specificity killing patterns are both restricted to the larger cells within a clone but may be expressed independently in clones from different mouse strains.
    Shortman K; Wilson A
    J Immunol; 1986 Aug; 137(3):798-804. PubMed ID: 2424983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide.
    Lethé B; van den Eynde B; van Pel A; Corradin G; Boon T
    Eur J Immunol; 1992 Sep; 22(9):2283-8. PubMed ID: 1381312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent immunodominant and immunorecessive tumor-specific antigens on a malignant tumor: antigenic dissection with cytolytic T cell clones.
    Wortzel RD; Urban JL; Philipps C; Fitch FW; Schreiber H
    J Immunol; 1983 May; 130(5):2461-6. PubMed ID: 6187859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes.
    Achour A; Begue B; Gomard E; Paul P; Sayagh B; Van Pel A; Levy JP
    Eur J Immunol; 1986 Jun; 16(6):597-604. PubMed ID: 3522244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.